Regulator rules on Disney bid level for Sky (SKY)
Royal Bank of Scotland Group (RBS) bankers knowingly sold ‘total garbage’ toxic mortgages, internal emails show
Hikma Pharmaceuticals (HIK) impresses the City with raised forecasts for 2018
Admiral Group (ADM) staff cash in after car insurer weathers Beast from the East freeze
FTSE slumps to four-month low as the shine comes off copper. Antofagasta (ANTO) shed 50.2p to 836.2p as its post-results slump continued, while Glencore (GLEN) dropped 17.9p to 298.5p, a 13-month low, and Anglo American (AAL) sank 102p to £15.42, its worst level this year.
Brent crude slumped as much as 3pc to $70.60 per barrel after stockpiles climbed at their fastest pace since March 2017. BP (BP.) and Royal Dutch Shell ‘B’ (RDSB) dropped 10.3p to 545p and 47.5p to £24.88, while Premier Oil (PMO) was the sector’s worst performer, sinking 9.6p to 108.6p
GlaxoSmithKline (GSK) was one of just seven stocks on the FTSE 100 to avoid the sell-off. Its shares were given a shot in the arm by positive results in a trial for its two-drug HIV treatment, boosting it 30.4p to 15.90.
Mitchells & Butlers (MAB) jumped 1.6p to 248.6p after HSBC upgraded it to buy, citing “robust sales” and its investment programme.
Balfour Beatty (BBY) sitting pretty as selective approach pays off